✦ LIBER ✦

PMH34 COST-EFFECTIVENESS OF OLANZAPINE VERSUS LITHIUM FOR THE PREVENTION OF RELAPSE IN BIPOLAR I DISORDER IN AUSTRALIA

✍ Scribed by N Price; P Davey; M Mudge; B Fitzgerald; N Rajan; B Montgomery

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH24: COST-EFFECTIVENESS OF ESCITALOPRA

✍ D Servant; SA Montgomery; C François; N Despiegel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Olanzapine superior to lithium for preve

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

PMH15 COST-EFFECTIVENESS OF QUETIAPINE I

✍ L Fajutrao; JC Locklear; S Liu; OB Paulson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

EPA-0989 – Cost-effectiveness of atypica

✍ Komarov, I.; Kulikov, A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 54 KB

PMH37 Cost-Effectiveness of Asenapine in

✍ J. Lachaine; C. Beauchemin; K. Mathurin; D. Gilbert; M. Beillat; H. Corson 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness of atypical antipsych

✍ Kulikov, A.; Komarov, I. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB